Literature DB >> 10845592

mRNA in situ hybridization of TIGR/MYOC in human trabecular meshwork.

X Wang1, D H Johnson.   

Abstract

PURPOSE: To determine the distribution of mRNA expression of the trabecular meshwork-induced glucocorticoid response protein/myocilin (TIGR/MYOC) in human trabecular meshwork.
METHODS: In situ hybridization using a 1.25-kb probe obtained from reverse transcription-polymerase chain reaction of TIGR/MYOC cDNA was performed to determine the location of cell labeling within the different regions of the meshwork. The effect of dexamethasone on the pattern of labeling was studied in organ cultured meshwork. Trabecular meshwork from three sources was studied: enucleated eyes obtained at autopsy, trabeculectomy specimens obtained during filtration surgery, and meshworks from anterior segments in perfusion organ culture. Hybridization was performed on frozen sections, paraffin sections, and sections from JB-4 plastic-embedded tissue.
RESULTS: Labeling for TIGR/MYOC mRNA was present in most trabecular cells of the uveal, corneoscleral, and juxtacanalicular regions but only variably present in the endothelial cells of Schlemm's canal. A similar pattern was found in the trabeculectomy specimens from eyes with primary open-angle or pseudoexfoliative glaucoma. Dexamethasone treatment increased the labeling intensity and number of labeled cells in meshwork, and also the number of labeled endothelial cells of Schlemm's canal. Fresh tissue processed within 12 hours postmortem gave more consistent labeling than older tissue, although some label was found up to 48 hours postmortem. Labeling was found in tissue from all three sources, and with all three embedding techniques; JB-4 sections provided the best morphologic resolution.
CONCLUSIONS: In situ hybridization reveals that mRNA expression for TIGR/MYOC is present in most cells in all regions of the meshwork but only variably present in the endothelial cells of Schlemm's canal. Dexamethasone treatment increased the number and intensity of labeled cells, and also increased the number of labeled cells in the endothelial lining of Schlemm's canal.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845592

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

Review 2.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

3.  Myocilin in the trabecular meshwork of eyes with primary open-angle glaucoma.

Authors:  Dirk D Konz; Cassandra Flügel-Koch; Andreas Ohlmann; Ernst R Tamm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-07       Impact factor: 3.117

4.  Little evidence for association of the glaucoma gene MYOC with open-angle glaucoma.

Authors:  Seongsoo Sohn; Wonhee Hur; Young Ran Choi; Yun Shin Chung; Chang-Seok Ki; Changwon Kee
Journal:  Br J Ophthalmol       Date:  2010-05       Impact factor: 4.638

5.  Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells.

Authors:  Yuan He; Kar Wah Leung; Ye-Hong Zhuo; Jian Ge
Journal:  Mol Vis       Date:  2009-04-23       Impact factor: 2.367

6.  Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells.

Authors:  Lina Wang; Yehong Zhuo; Bingqian Liu; Shengsong Huang; Fei Hou; Jian Ge
Journal:  Mol Vis       Date:  2007-04-19       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.